Genomtec Investor Relations Material
Latest events
Investor Update
Genomtec
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Genomtec S.A
Access all reports
Genomtec S.A. is a biotechnology company specializing in molecular diagnostics. The company develops and commercializes portable and laboratory-based diagnostic solutions using isothermal nucleic acid amplification technology. Its products are designed for rapid and precise detection of infectious diseases, genetic disorders, and other medical conditions. The company is headquartered in Wrocław, Poland, and its shares are listed on the WSE.
Key slides for Genomtec S.A
Investor Update
Genomtec S.A
Investor Update
Genomtec S.A
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
GMT
Country
🇵🇱 Poland